Pharmacokinetics, Pharmacodynamics, and Safety of GB001 in Healthy Non-Asian, Non-Japanese Asian and Japanese Subjects

J. Shen , M. Yamashita , G.J. Opiteck , K. Raghupathi
B31. ASTHMA CLINICAL TRIALS

2020
GB001 Is a Differentiated Potent Prostaglandin D2 Antagonist with Long Receptor Residence Time and Extended Pharmacodynamic Efficacy

K. Taylor Meadows , S. Sahdeo , S. Murphy , G.J. Opiteck
D69. ASTHMA SUBPHENOTYPES, TARGETS AND THERAPEUTICS

2020
Overview of nanoelectronic devices

D. Goldhaber-Gordon , M.S. Montemerlo , J.C. Love , G.J. Opiteck
Proceedings of the IEEE 85 ( 4) 521 -540

327
1997
Comprehensive on-line RPLC-CZE-MS of peptides

K LEWIS , G OPITECK , J JORGENSON , D SHEELEY
Journal of the American Society for Mass Spectrometry 8 ( 5) 495 -500

128
1997
Photochemical protease: site-specific photocleavage of hen egg lysozyme and bovine serum albumin.

C. V. Kumar , A. Buranaprapuk , G. J. Opiteck , M. B. Moyer
Proceedings of the National Academy of Sciences of the United States of America 95 ( 18) 10361 -10366

69
1998
UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study.

Y-H Wang , M Trucksis , J J McElwee , P H Wong
Clinical Pharmacology & Therapeutics 92 ( 1) 96 -102

32
2012
Fr150 GB004 EXHIBITS PROTECTIVE EFFECTS DIRECTLY ON EPITHELIAL CELLS USING EX VIVO ORGANOID AND MONOLAYER CULTURES

Gregory J. Opiteck , Susan Murphy , Laura Carter , Luisa Salter-Cid
Gastroenterology 160 ( 6)

2021
Fr206 NOVEL BLOOD-BASED BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS

Morten Asser Karsdal , Joachim H⊘g Mortensen , Gregory J. Opiteck , Arjan Bredenoord
Gastroenterology 160 ( 6)

2021
Evaluation of early biomarkers of muscle anabolic response to testosterone.

Fabian Chen , Raymond Lam , David Shaywitz , Ronald C. Hendrickson
Journal of Cachexia, Sarcopenia and Muscle 2 ( 1) 45 -56

27
2011
A Multidimensional Approach to Protein Characterization

Robert J. Anderegg , David S. Wagner , R. Kevin Blackburn , Gregory J. Opiteck
Journal of Protein Chemistry 16 ( 5) 523 -526

16
1997
N-Terminal Propeptide of Type III Procollagen as a Biomarker of Anabolic Response to Recombinant Human GH and Testosterone

Jeffrey A. Tsou , Carmen Castaneda-Sceppa , Ellen F. Binder , Stanley P. Azen
The Journal of Clinical Endocrinology and Metabolism 94 ( 11) 4224 -4233

71
2009
Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study

Evan S. Dellon , Margaret H. Collins , Yehudith Assouline-Dayan , Larry Evans
The Journal of Allergy and Clinical Immunology 143 ( 2)

5
2019
Peptide Shifter: Enhancing Separation Reproducibility Using Correlated Expression Profiles

Dmitri Sitnikov , Joanna M. Hunter , Clive Hayward , Kevin Eng
Journal of the American Society for Mass Spectrometry 18 ( 9) 1638 -1645

1
2007
Guidelines for the routine application of the peptide hits technique.

Ji Gao , Mark S. Friedrichs , Ashok R. Dongre , Gregory J. Opiteck
Journal of the American Society for Mass Spectrometry 16 ( 8) 1231 -1238

52
2005
The oxidation of [Co(edta)]2− by [Co(phen)3]3+

Robert M.L. Warten , Lars Öhrström , Gregory J. Opiteck , Maoyu Shang
Inorganica Chimica Acta 225 75 -82

13
1994
Biomarker discovery in biological fluids.

Ji Gao , Leah-Ann Garulacan , Stephen M. Storm , Gregory J. Opiteck
Methods 35 ( 3) 291 -302

81
2005
Rapid separation and characterization of protein and peptide mixtures using 1.5 μm diameter non-porous silica in packed capillary liquid chromatography/mass spectrometry

John E. MacNair , Gregory J. Opiteck , James W. Jorgenson , M. Arthur Moseley
Rapid Communications in Mass Spectrometry 11 ( 12) 1279 -1285

40
1997
Mo1105 GB004, A NOVEL GUT-TARGETED PROLYL HYDROXYLASE INHIBITOR, INDUCES HIF-1ALPHA TARGET GENES AND IS EFFICACIOUS IN MOUSE COLITIS

Kristen Taylor Meadows , Michael Kennedy , Zachary Naiman , Masha Sergeeva
Gastroenterology 158 ( 6)

2020